Johnson & Johnson (JNJ) - Pharmaceutical Research & Development (DISCONTINUED) (I:JJJNJPRD)
Level Chart
Basic Info
Johnson & Johnson (JNJ) - Pharmaceutical Research & Development is at a current level of 11.62B, up from 9.563B one year ago. This is a change of 21.53% from one year ago. |
Pharmaceutical Research & Development refers to the activities and investments made by Johnson & Johnson in the research and development of new pharmaceutical products and innovations within its pharmaceutical segment. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 11.62B |
Latest Period | 2023 |
Last Updated | Jan 12 2024, 16:52 EST |
Average Growth Rate | 8.31% |
Value from 1 Year Ago | 9.563B |
Change from 1 Year Ago | 21.53% |
Frequency | Yearly |
Unit | USD |
Adjustment | N/A |
Historical Data
Date | Value |
---|---|
January 01, 2023 | 11.62B |
January 02, 2022 | 11.88B |
January 03, 2021 | 9.563B |
December 29, 2019 | 8.834B |
December 30, 2018 | 8.446B |
December 31, 2017 | 8.392B |
Date | Value |
---|---|
January 01, 2017 | 7.001B |
January 03, 2016 | 6.821B |
December 28, 2014 | 6.213B |
December 29, 2013 | 5.81B |
December 30, 2012 | 5.362B |
News
Basic Info
Johnson & Johnson (JNJ) - Pharmaceutical Research & Development is at a current level of 11.62B, up from 9.563B one year ago. This is a change of 21.53% from one year ago. |
Pharmaceutical Research & Development refers to the activities and investments made by Johnson & Johnson in the research and development of new pharmaceutical products and innovations within its pharmaceutical segment. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 11.62B |
Latest Period | 2023 |
Last Updated | Jan 12 2024, 16:52 EST |
Average Growth Rate | 8.31% |
Value from 1 Year Ago | 9.563B |
Change from 1 Year Ago | 21.53% |
Frequency | Yearly |
Unit | USD |
Adjustment | N/A |